HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $598 | +1.7% | 15,678 | -3.9% | 0.01% | +14.3% |
| Q2 2023 | $588 | -17.3% | 16,313 | -12.4% | 0.01% | -12.5% |
| Q1 2023 | $711 | -34.0% | 18,621 | -1.6% | 0.01% | -38.5% |
| Q4 2022 | $1,077 | -99.9% | 18,929 | -1.0% | 0.01% | +30.0% |
| Q3 2022 | $755,000 | -13.4% | 19,114 | -3.6% | 0.01% | -9.1% |
| Q2 2022 | $872,000 | +10.5% | 19,819 | +0.1% | 0.01% | +37.5% |
| Q1 2022 | $789,000 | -3.7% | 19,809 | -2.8% | 0.01% | 0.0% |
| Q4 2021 | $819,000 | -7.8% | 20,379 | -6.7% | 0.01% | -11.1% |
| Q3 2021 | $888,000 | -5.8% | 21,844 | +5.1% | 0.01% | -10.0% |
| Q2 2021 | $943,000 | +13.6% | 20,785 | +4.3% | 0.01% | +11.1% |
| Q1 2021 | $830,000 | -5.8% | 19,923 | -3.5% | 0.01% | -10.0% |
| Q4 2020 | $881,000 | – | 20,647 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |